课题基金 / 基金详情

EFFICACY AND SAFETY OF MIBEFRADIL W/ VERAPAMIL IN MILD TO MODERATE HYPERTENSION

EFFICACY AND SAFETY OF MIBEFRADIL W/ VERAPAMIL IN MILD TO MODERATE HYPERTENSION
米贝拉地尔联合维拉帕米治疗轻至中度高血压的疗效和安全性
批准号：
6280115
负责人：
BRENT M EGAN
金额：
$2.73万
依托单位：
MEDICAL UNIVERSITY OF SOUTH CAROLINA
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6280115
关键词：
calcium channel blockers cardiovascular disorder chemotherapy clinical research clinical trials combination chemotherapy drug screening /evaluation human subject human therapy evaluation hypertension vasodilators verapamil

项目摘要

项目成果

BRENT M EGAN的其他基金

相关文献

中文摘要
翻译
多中心、单盲、安慰剂导入、双盲、随机化 灵活的滴定，平行比较的疗效和安全性 米贝拉地尔联合维拉帕米缓释剂治疗轻中度 高血压
英文摘要
Multicenter, single-blind, placebo run-in, double-blind, randomized flexible titration, parallel comparison of the efficacy and safety of mibefradil with verapamil SR in patients with mild to moderate hypertension
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
PROTEOMIC ANALYSIS OF BLOOD: ZN-ALPHA-2-GLYCOPROTEIN AS A BIOMARKER FOR CACHE
FATTY ACIDS, ANGIOTENSIN AND OXIDATIVE STRESS